Related Experiment Video
Updated: Jul 7, 2025

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
Published on: January 5, 2016
Cholesterol Metabolism in Antigen-Presenting Cells and HIV-1 Trans-Infection of CD4+ T Cells
Daniel Okpaise1, Nicolas Sluis-Cremer1, Giovanna Rappocciolo1
1Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Insights
Non-progressing HIV-1 patients prevent viral spread through altered cholesterol metabolism in their cells. This cellular mechanism blocks HIV-1 trans-infection, offering insights into potential cures.
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- Antiretroviral therapy (ART) manages HIV-1 but cannot eliminate the latent viral reservoir.
- Latent HIV-1 persists in resting CD4+ T cells, posing a barrier to a cure.
- Intercellular HIV-1 transfer (trans-infection) from antigen-presenting cells (APCs) to CD4+ T cells establishes this reservoir and is ART-resistant.
Approach:
- This review examines the unique characteristic of HIV-1-positive non-progressors (NPs) who control infection without ART.
- The focus is on the proposed genetically inherited, altered cholesterol metabolism in the APCs of NPs.
- The role of cellular cholesterol homeostasis and efflux in preventing HIV-1 trans-infection in NPs is investigated.
Key Points:
- APCs from NPs do not trans-infect CD4+ T cells, unlike those from typical HIV-1 patients.
- Altered cholesterol metabolism in NP APCs is hypothesized to be the driving force behind this protective mechanism.
- Cholesterol efflux from APCs is identified as a critical factor in blocking HIV-1 trans-infection.
Conclusions:
- Understanding the link between cholesterol metabolism and HIV-1 trans-infection in NPs is crucial for developing a functional HIV-1 cure.
- Targeting cholesterol pathways may offer novel therapeutic strategies to clear the latent HIV-1 reservoir.
- The findings highlight the potential of host-intrinsic factors in controlling viral persistence.
Abstract:
Antiretroviral therapy (ART) provides an effective method for managing HIV-1 infection and preventing the onset of AIDS; however, it is ineffective against the reservoir of latent HIV-1 that persists predominantly in resting CD4+ T cells. Understanding the mechanisms that facilitate the persistence of the latent reservoir is key to developing an effective cure for HIV-1. Of particular importance in the establishment and maintenance of the latent viral reservoir is the intercellular transfer of HIV-1 from professional antigen-presenting cells (APCs-monocytes/macrophages, myeloid dendritic cells, and B lymphocytes) to CD4+ T cells, termed trans-infection. Whereas virus-to-cell HIV-1 cis infection is sensitive to ART, trans-infection is impervious to antiviral therapy. APCs from HIV-1-positive non-progressors (NPs) who control their HIV-1 infection in the absence of ART do not trans-infect CD4+ T cells. In this review, we focus on this unique property of NPs that we propose is driven by a genetically inherited, altered cholesterol metabolism in their APCs. We focus on cellular cholesterol homeostasis and the role of cholesterol metabolism in HIV-1 trans-infection, and notably, the link between cholesterol efflux and HIV-1 trans-infection in NPs.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cell-mediated Immune Responses
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...

